Stay updated with breaking news from Rog Eb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher Shares of Tempest Therapeutics rose more than sevenfold in premarket trading Wednesday after the clinical-stage oncology company reported...
By Colin Kellaher AbbVie on Friday said a Phase 3 study evaluating the safety and efficacy of its venetoclax cancer drug in combination with dexamethasone...
By Giulia Petroni Roche said the U.K.'s medicines regulator has approved its Tecentriq intravenous cancer therapy. The Swiss pharmaceutical company said...
By Adria Calatayud Shares in Roche Holding rose Wednesday after the company released interim results from a late-stage clinical trial of a combination of two...
By Adria Calatayud Roche Holding on Thursday backed its guidance for 2023 after lower sales of products related to Covid-19 in the first half weighed on its...